{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Neuraceq", "query": { "intervention": "Neuraceq" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 17, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Neuraceq&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-07T01:49:58.728Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04105634", "title": "Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Cardiac Amyloidosis" ], "interventions": [ { "name": "FNOS", "type": "DRUG" }, { "name": "Florbetaben", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2019-10-01", "completion_date": "2024-10-14", "has_results": false, "last_update_posted_date": "2024-11-12", "last_synced_at": "2026-09-07T01:49:58.728Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04105634" }, { "nct_id": "NCT07787182", "title": "A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers", "Alzheimer Disease", "Amyloid", "Plaque, Amyloid" ], "interventions": [ { "name": "LY4405094", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Florbetapir F18", "type": "OTHER" }, { "name": "Florbetaben F 18", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 68, "start_date": "2026-09", "completion_date": "2028-01", "has_results": false, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-09-07T01:49:58.728Z", "location_count": 10, "location_summary": "Irvine, California • Daytona Beach, Florida • Lady Lake, Florida + 7 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Daytona Beach", "state": "Florida" }, { "city": "Lady Lake", "state": "Florida" }, { "city": "Maitland", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07787182" }, { "nct_id": "NCT04720001", "title": "Florbetaben PET Imaging in PPA", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Primary Progressive Aphasia", "Alzheimer Disease" ], "interventions": [ { "name": "Florbetaben F18", "type": "DRUG" }, { "name": "PET", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 1, "start_date": "2018-08-23", "completion_date": "2021-02-26", "has_results": false, "last_update_posted_date": "2024-10-16", "last_synced_at": "2026-09-07T01:49:58.728Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04720001" }, { "nct_id": "NCT03744312", "title": "Imaging Inflammation in Alzheimer's Disease With 11C-ER176", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "11C-ER176", "type": "DRUG" }, { "name": "Florbetaben", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 9, "start_date": "2018-09-10", "completion_date": "2022-07-20", "has_results": true, "last_update_posted_date": "2025-04-17", "last_synced_at": "2026-09-07T01:49:58.728Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03744312" }, { "nct_id": "NCT05617014", "title": "Alzheimer's Disease Neuroimaging Initiative 4", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Mild Cognitive Impairment", "Alzheimer Disease", "Dementia" ], "interventions": [ { "name": "Neuraceq", "type": "RADIATION" }, { "name": "Amyvid", "type": "RADIATION" }, { "name": "Tauvid", "type": "RADIATION" }, { "name": "MK-6240", "type": "RADIATION" }, { "name": "NAV4694", "type": "RADIATION" }, { "name": "PI-2620", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "55 Years to 90 Years" }, "enrollment_count": 1500, "start_date": "2023-06-09", "completion_date": "2027-07-31", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-09-07T01:49:58.728Z", "location_count": 62, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Sun City, Arizona + 46 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05617014" }, { "nct_id": "NCT07787169", "title": "A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer Disease", "Amyloid", "Plaque, Amyloid", "Healthy Volunteers" ], "interventions": [ { "name": "LY4405094", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Florbetapir F18", "type": "OTHER" }, { "name": "Florbetaben F 18", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 179, "start_date": "2026-09", "completion_date": "2028-07", "has_results": false, "last_update_posted_date": "2026-08-27", "last_synced_at": "2026-09-07T01:49:58.728Z", "location_count": 10, "location_summary": "Irvine, California • Daytona Beach, Florida • Lady Lake, Florida + 7 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Daytona Beach", "state": "Florida" }, { "city": "Lady Lake", "state": "Florida" }, { "city": "Maitland", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07787169" }, { "nct_id": "NCT06303921", "title": "Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Tauopathies" ], "interventions": [ { "name": "11C-M503 PET", "type": "DRUG" }, { "name": "Brain MRI", "type": "DIAGNOSTIC_TEST" }, { "name": "Amyloid PET", "type": "DIAGNOSTIC_TEST" }, { "name": "Neurological assessments", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST", "BEHAVIORAL" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 70, "start_date": "2024-02-16", "completion_date": "2029-02", "has_results": false, "last_update_posted_date": "2026-04-24", "last_synced_at": "2026-09-07T01:49:58.728Z", "location_count": 3, "location_summary": "New Haven, Connecticut • St Louis, Missouri • Philadelphia, Pennsylvania", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06303921" }, { "nct_id": "NCT06932809", "title": "Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Tauopathies" ], "interventions": [ { "name": "18F-JSS20-183A PET", "type": "DRUG" }, { "name": "Brain MRI", "type": "DIAGNOSTIC_TEST" }, { "name": "Amyloid PET", "type": "DIAGNOSTIC_TEST" }, { "name": "Neurological Assessments", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST", "BEHAVIORAL" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 90, "start_date": "2025-05-09", "completion_date": "2030-04", "has_results": false, "last_update_posted_date": "2025-12-23", "last_synced_at": "2026-09-07T01:49:58.728Z", "location_count": 2, "location_summary": "San Francisco, California • Philadelphia, Pennsylvania", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06932809" }, { "nct_id": "NCT03507257", "title": "Longitudinal Early-onset Alzheimer's Disease Study Protocol", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Early Onset Alzheimer Disease", "Alzheimer Disease", "Mild Cognitive Impairment" ], "interventions": [ { "name": "Flortaucipir", "type": "DRUG" }, { "name": "Florbetaben", "type": "DRUG" }, { "name": "Fluorodeoxyglucose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "40 Years to 64 Years" }, "enrollment_count": 850, "start_date": "2018-04-30", "completion_date": "2027-01-01", "has_results": false, "last_update_posted_date": "2026-07-29", "last_synced_at": "2026-09-07T01:49:58.728Z", "location_count": 18, "location_summary": "Sun City, Arizona • Los Angeles, California • Palo Alto, California + 15 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03507257" }, { "nct_id": "NCT03119558", "title": "PET/MRI Evaluation of Cardiac Amyloid", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Cardiac Amyloidosis" ], "interventions": [ { "name": "18F-Florbetaben (Neuraceq®) PET/MRI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 9, "start_date": "2016-05-26", "completion_date": "2018-08-28", "has_results": false, "last_update_posted_date": "2019-07-17", "last_synced_at": "2026-09-07T01:49:58.728Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03119558" } ] }